Bristol-Myers Squibb Presents Ipilimumab Phase 2 Results
Ipilimumab is a T-cell potentiator that specifically blocks the inhibitory signal of CTLA-4 (cytotoxic T lymphocyte-associated antigen 4), a molecule on T-cells that plays a critical role in
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
PerkinElmer and Abbott’s presentation will be based on their work together incorporating PerkinElmer’s exact mass TOF technology as part of Abbott’s Plex-ID detection platform, employed in pathogen detection
Spectrum Chemicals & Laboratory Products manufactures and distributes fine chemicals and laboratory products. Spectrum’s chemical offering consists of over 15,000 active pharmaceutical ingredients (API’s), excipients, biochemicals, nutraceuticals, cosmetic